KTN's online platform helps you to make the connections you need

 

The Knowledge Transfer Network (KTN) has refreshed its online platform to intelligently connect you to relevant events, funding, thought pieces and specialist staff to help your business innovate and grow.

You can discover content using your area of interest, from Defence Security to transport; from space to health – all major UK economic sectors are covered. Once you have selected your interests, using our intelligent tagging system, we will then display rich and relevant content related to your area, often from surprising sources.

An example might be new satellite technology from the space sector that is applicable in the agri-food sector. KTN-UK.co.uk will help you form these unusual and valuable connections.

All content on the platform has been carefully curated by our team of innovation specialists – not by an automated algorithm – so you can be confident that KTN is connecting you to the most relevant cutting-edge information.

 

The move also marks a closer alignment with our main funder, Innovate UK , with the website branding making a clear visual link. Knowledge Transfer Network is Innovate UK's innovation network partner, and also works with other funders to provide innovation networking services and fulfil our mission to drive UK growth.

We link new ideas and opportunities with expertise, markets and finance through our network of businesses, universities, funders and investors. From agri-food to autonomous systems and from energy to design, KTN combines expertise in all sectors with the ability to cross boundaries. Connecting with KTN can lead to potential partners, horizon-expanding events and innovation insights relevant to your needs.

Visit our people pages to connect directly with expertise in your sector.

Visit the KTN refreshed online platfom here

Entries with tag pharma .

Manufacturing and materials competition

Innovate UK has announced the opening of its Manufacturing and materials competition, offering support totalling up to £15 million for manufacturing and materials projects that could lead to increased productivity, competitiveness and growth, especially for SMEs. The type of projects Innovate UK seeks to support are those that focus on technical feasibility, industrial research or...
Read More About Manufacturing and materials competition »

The future of biopharmaceutical formulation - making better products with novel approaches

KTN Biopharmaceutical Formulation Group The future of biopharmaceutical formulation - making better products with novel approaches UCL, London Thursday 7th July, 2016 The KTN’s Biopharmaceutical Formulation Group will meet on 7th July at an event hosted by the EPSRC Centre for Innovative Manufacturing at UCL. The event is an opportunity to hear from industry and academia in...
Read More About The future of biopharmaceutical formulation - making better products with novel approaches »

Pharmaceutical Business Development in the Digital Health Sector - Current trends & future impact

Pharmaceutical Business Development in the Digital Health Sector - Current trends & future impact 19th May London Innovation in the digital world is changing the landscape for the Pharma industry and healthcare in general. New technology is influencing areas from diagnostics and personalised medicine to new product development, compliance and patient support programmes. In turn...
Read More About Pharmaceutical Business Development in the Digital Health Sector - Current trends & future impact »

Johnson Matthey and Domainex Collaborate to Enhance Discovery and Development Services for UK Pharma, Biotech and Academia

Johnson Matthey, a leading provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies and Domainex Ltd. (Cambridge, UK), a small-molecule drug discovery company, have announced a collaboration to provide integrated small molecule pharmaceutical discovery and development services. The focus will be on providing academic institutes, biotechnology...
Read More About Johnson Matthey and Domainex Collaborate to Enhance Discovery and Development Services for UK Pharma, Biotech and Academia »

Health Data Analytics in Japan - Big Opportunities for UK Companies: Webinar

UKTI Japan Webinar Big Data Analytics Japan 10.00am on Tue 26 April   The primary focus of this webinar is on the Japanese market related to Big Data, but as data analytics connects to an ever increasing spectrum of businesses and sectors including Biotech, Pharma, Medical and Healthcare, we believe there will be a lot of relevant information to your industry when...
Read More About Health Data Analytics in Japan - Big Opportunities for UK Companies: Webinar »

Autolus Limited secures £40 million funding

Autolus Limited (“Autolus”), a biopharmaceutical company focused on the development and commercialisation of next-generation engineered T-cell therapies for haematological and solid tumours, announced today that it has raised £40 million of new capital in a Series B financing round. Woodford Investment Management LLP (“Woodford”) and Perceptive Bioscience Investments Ltd (“Perceptive...
Read More About Autolus Limited secures £40 million funding »

Biopharmaceutical Analytical Group Symposium : Agenda Now Online

Biopharmaceutical Analytical Group Symposium March 15th -16th 2016 Registration is now open.   The Centre of Process Innovation and KTN present the 3rd Biopharmaceutical Analytical Group Symposium to be held at the recently launched National Biologics Manufacturing Centre in Darlington. Speakers will present on key topics and the latest developments in analytical...
Read More About Biopharmaceutical Analytical Group Symposium : Agenda Now Online »

ADDoPT set to transform UK pharmaceutical development and manufacturing through £20.4m project

ADDoPT is a four-year collaboration between government, industry and academia supported by AMSCI funding. Led by Process Systems Enterprise and supported by the Medicines Manufacturing Industry Partnership (MMIP), it involves pharmaceutical companies Pfizer, GlaxoSmithKline, AstraZeneca and Bristol-Myers Squibb, as well as leading UK universities, research centres, and knowledge-driven...
Read More About ADDoPT set to transform UK pharmaceutical development and manufacturing through £20.4m project »

Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance

On January 21, 2016, the Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance was launched at an event at the World Economic Forum in Davos, Switzerland. This was drafted, agreed and signed by 85 companies and nine industry associations from across the global pharmaceutical, diagnostics and biotechnology industries in...
Read More About Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance »

New Drug Approvals Hit 66-Year High

2015 has been a remarkable year for pharmaceutical innovation. What would have been a dream (or perhaps a delusion) a few years ago has happened. Last year’s new drug approvals reached 51 , besting every year since 1950. This tally includes 45 drugs approved by FDA’s Center for Drug Evaluation and Research (CDER), and 6 recombinant therapies approved by the Center for Biologics...
Read More About New Drug Approvals Hit 66-Year High »

Self-monitoring service for patients using anticoagulation drug Warfarin.

Isle of Wight Clinical Commissioning Group is piloting a self-monitoring service for patients using anticoagulation drug Warfarin. The CCG is the first to launch the new automated service from Inhealthcare, with the aim of relieving pressure on warfarin clinics. The system allows patients to self-test at home and receive their adjusted warfarin dose via INRstar anticoagulation dosing...
Read More About Self-monitoring service for patients using anticoagulation drug Warfarin. »

SWLSTG Pharmacy Services develop innovative free app for safe lithium treatment

Pharmacy Services at South West London and St George's Mental Health NHS Trust (SWLSTG) have developed an innovative app that will be available for free to help with the safe prescribing, administering and monitoring of lithium. In the UK, Lithium Carbonate (often referred to as Lithium) is the medication most commonly used to treat bipolar disorder. For lithium to be effective, the...
Read More About SWLSTG Pharmacy Services develop innovative free app for safe lithium treatment »

Quotient Clinical expands its formulation development services with the acquisition of Co-Formulate in Nottingham

Quotient Clinical, the Translational Pharmaceutics® company, has announced that it has acquired formulation development specialist Co-Formulate Limited.  Quotient Clinical has brought innovation to the drug development process through its unique Translational Pharmaceutics platform, which challenges the conventional industry approach by integrating formulation development,...
Read More About Quotient Clinical expands its formulation development services with the acquisition of Co-Formulate in Nottingham »

Opportunities and Challenges in Japan Pharma and Medical Device Market Entry

Opportunities And Challenges In Japan Pharma and Medical Device Market Entry Thursday 21 January  9:00-9:45 am, UK Time (Presentation and Q&A) Online event Free UK Trade & Investment Japan Life Sciences Team is organising the webinar on opportunities and challenges for Pharma and Medical Device market entry.     The revised law...
Read More About Opportunities and Challenges in Japan Pharma and Medical Device Market Entry »

Piramal invests in Scotland site offering

Piramal Enterprises' Pharma Solutions division announced that it is looking to strengthen its position in contract commercialization of antibody-drug conjugates (ADCs) over the next five years. The CDMO has introduced a new “Proof of Concept” service, designed to bring the most promising targets into clinical development more quickly. Piramal, now in its fifth year of...
Read More About Piramal invests in Scotland site offering »

Funding for analytical technologies for biopharmaceutical processes

Innovate UK is to invest up to £4M in collaborative R&D projects to address the UK biopharmaceutical industry’s need for improved analytical technologies to support the development of current and next generation biopharmaceutical products.   About the funding This competition seeks to advance the development and commercialisation of Biopharmaceutical products and...
Read More About Funding for analytical technologies for biopharmaceutical processes »

Pharma Sciences Symposium 2016

Takeda Science Foundation is organising the 8th Pharma Sciences symposium on 21-22 January 2016 in Osaka, Japan. Under the theme of “Biomolecule-Based Medicinal Science: Featuring Mid-Size Drugs”, the globally renowned researchers will be speaking at the symposium. One of the main topics will be the application of peptide to drug discovery and development. The symposium primarily targets...
Read More About Pharma Sciences Symposium 2016 »

Major Danish Pharmaceutical Seeking technology partners within protein discovery

A global pharmaceutical company based in Denmark is seeking potential partners within the area of protein discovery and peptide based therapeutics. Specifically, the company is interested in engaging with early stage, pre commercial or spin out technology or biotechnology companies.  Click here for more details.  
Read More About Major Danish Pharmaceutical Seeking technology partners within protein discovery »

Shionogi Pharma Talks R&D Collaboration Webinar now online

The UK Trade & Investment Japan webinar “Shionogi Pharma Talks R&D Collaboration” is now available at exporttojapan.co.uk .     Presentation slides from the event are also avliable here .    In the webinar on 29 September.   Shionogi & Co Ltd , a Japanese leading pharmaceutical company, gave the overview of their...
Read More About Shionogi Pharma Talks R&D Collaboration Webinar now online »
Showing 19 results.
Items per Page 25
of 1